Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Ricardo Antonio Tan & Jonathan Corren. (2014) Clinical utility and development of the fluticasone/formoterol combination formulation (Flutiform®) for the treatment of asthma. Drug Design, Development and Therapy 8, pages 1555-1561.
Read now
Read now
Anna Bodzenta-Lukaszyk, Roland Buhl, Beatrix Balint, Mark Lomax, Kay Spooner & Sanjeeva Dissanayake. (2012) Fluticasone/Formoterol Combination Therapy versus Budesonide/Formoterol for the Treatment of Asthma: A Randomized, Controlled, Non-Inferiority Trial of Efficacy and Safety. Journal of Asthma 49:10, pages 1060-1070.
Read now
Read now
Articles from other publishers (13)
Andrew Kouri, Louis-Philippe Boulet, Alan Kaplan & Samir Gupta. (2017) An evidence-based, point-of-care tool to guide completion of asthma action plans in practice. European Respiratory Journal 49:5, pages 1602238.
Crossref
Crossref
Douglas W. Mapel & Melissa H. Roberts. (2014) Management of Asthma and Chronic Obstructive Pulmonary Disease with Combination Inhaled Corticosteroids and Long-Acting β-Agonists: A Review of Comparative Effectiveness Research. Drugs 74:7, pages 737-755.
Crossref
Crossref
Toby J Lasserson, Giovanni Ferrara & Lucio Casali. (2011) Combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for chronic asthma in adults and children. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Anna Bodzenta-Lukaszyk, Andrzej Dymek, Kirsten McAulay & Heikki Mansikka. (2011) Fluticasone/formoterol combination therapy is as effective as fluticasone/salmeterol in the treatment of asthma, but has a more rapid onset of action: an open-label, randomized study. BMC Pulmonary Medicine 11:1.
Crossref
Crossref
Soichiro Hozawa, Michikazu Terada & Maki Hozawa. (2011) Comparison of budesonide/formoterol Turbuhaler with fluticasone/salmeterol Diskus for treatment effects on small airway impairment and airway inflammation in patients with asthma. Pulmonary Pharmacology & Therapeutics 24:5, pages 571-576.
Crossref
Crossref
S. J. Edwards, R. von Maltzahn, I. P. Naya & T. Harrison. (2010) Budesonide/formoterol for maintenance and reliever therapy of asthma: a meta analysis of randomised controlled trials. International Journal of Clinical Practice 64:5, pages 619-627.
Crossref
Crossref
G. Walter Canonica & Christopher Brightling. (2010) Section 3. A Discussion of Flexible Dosing and Patient-Centered Therapy. World Allergy Organization Journal 3:2, pages 31-37.
Crossref
Crossref
Lucie Blais, Marie-France Beauchesne & Amélie Forget. (2009) Acute care among asthma patients using budesonide/formoterol or fluticasone propionate/salmeterol. Respiratory Medicine 103:2, pages 237-243.
Crossref
Crossref
S. Aballéa, S. Cure, C. Vogelmeier & A. Wirén. (2008) A retrospective database study comparing treatment outcomes and cost associated with choice of fixed-dose inhaled corticosteroid/long-acting β2-agonists for asthma maintenance treatment in Germany. International Journal of Clinical Practice 62:12, pages 1870-1879.
Crossref
Crossref
Bertil Lindmark. (2008) Review: Differences in the pharmacodynamics of budesonide/formoterol and salmeterol/fluticasone reflect differences in their therapeutic usefulness in asthma. Therapeutic Advances in Respiratory Disease 2:5, pages 279-299.
Crossref
Crossref
Piotr Kuna & Izabela Kuprys-Lipinska. (2008) Budesonide/formoterol for maintenance and reliever therapy: new quality in asthma management. Therapy 5:4, pages 495-512.
Crossref
Crossref
Toby J Lasserson, Christopher J Cates, Giovanni Ferrara & Lucio Casali. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Jean Bousquet, Louis-Philippe Boulet, Matthew J. Peters, Helgo Magnussen, Joaquin Quiralte, Nora E. Martinez-Aguilar & Åsa Carlsheimer. (2007) Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone. Respiratory Medicine 101:12, pages 2437-2446.
Crossref
Crossref